Guaifenesin recalls
The FDA has published 11 recalls involving Guaifenesin since 2014. The latest was reported on 12 Feb 2025. Most were for labeling errors. Aidapak Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls11since 2014
Last 12 months0reported
Class I00% of total
Ongoing1latest 12 Feb 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 9 82%Class III 2 18%
Why guaifenesin is recalled
Companies
Brands
By year
Ongoing guaifenesin recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Guaifenesin Oral Solution, 300 mg/, Sugar Free/Alcohol Free recalled | Akorn | Potency & Assay | Nationwide |
All guaifenesin recalls, newest first
11 totalShould you stop taking Guaifenesin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.